Fibrogenic impact of high serum glucose in chro nic hepatitis C

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Volume 60, Issue 1, Pages (January 2014)

Volume 63, Issue 1, Pages (July 2015)

Volume 357, Issue 9262, Pages (April 2001)

Volume 46, Issue 3, Pages (March 2007)

Volume 32, Issue 2, Pages (February 2000)

VEGF levels in CSF and serum in mild ALS patients

The impact of hepatitis E in the liver transplant setting

Volume 56, Issue 1, Pages (January 2012)

A study on serum concentrations of oxidized low-density lipoprotein β2-glycoprotein I complex in patients with normal and dyslipidemic lipid profiles

Volume 67, Issue 3, Pages (September 2017)

Volume 50, Issue 4, Pages (April 2009)

Alan Hoofring, John Boitnott, Michael Torbenson Journal of Hepatology

Incorrect Calculation and Inappropriate Interpretation: Accuracy of International Guidelines for Identifying Significant Fibrosis in e Antigen–Negative.

Volume 42, Issue 6, Pages (June 2005)

Volume 61, Issue 6, Pages (December 2014)

Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar

The impact of hepatitis E in the liver transplant setting

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

Unraveling the genetic predisposition of ribavirin-induced anaemia

Natural history of hepatitis B

Impact of xenon anaesthesia in isolated cardiopulmonary bypass on very early leucocyte and platelet activation and clearance: a randomized, controlled.

HbA1c as a screening tool for cystic fibrosis related diabetes

Living donor liver transplantation: is the hype over?

Volume 44, Pages S19-S24 (January 2006)

Liver fibrosis in overweight patients

Volume 128, Issue 7, Pages (June 2005)

A. Mirakhur, M.J. Gallagher, M.J. Ledson, C.A. Hart, M.J. Walshaw

AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary.

Supplemental oxygen and surgical site infection: getting to the truth

Peripheral neuropathy in cystic fibrosis: A prevalence study

Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure” Rakhi Maiwall,

Chronic HCV infection and the clonality of intrahepatic T cells

Parkinson's disease and anaesthesia

Familial amyloid polyneuropathy and liver transplantation

TLL1 rs Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C Miya John, Mayada Metwally Gastroenterology

Laura Viviani, Baroukh M. Assael, Eitan Kerem

Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease

Volume 62, Issue 3, Pages (March 2015)

John Widger, Sarath Ranganathan, Philip J. Robinson

Genomic risk of hepatitis C-related hepatocellular carcinoma

Anouk Dev, Keyur Patel, Andrew Conrad, Lawrence M. Blatt, John G

Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore

Volume 44, Issue 6, Pages (June 2006)

Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study Christine Rønne.

I Meyts, W Wuyts, M Proesmans, K De Boeck Journal of Cystic Fibrosis

Cystic fibrosis related diabetes in an extremely young patient

Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease Sylvie Naveau, Bruno Raynard, Vlad Ratziu, Annie Abella,

Volume 50, Issue 4, Pages (April 2009)

Anastasios Lekkas, Khin M. Gyi, Margaret E. Hodson

Volume 135, Issue 1, Pages (July 2008)

Marie-Angela Schnyder, Christian Benden, Christoph Schmid

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Testing patients with non-specific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about.

Sharon J. Hutchinson, Sheila M. Bird, David J. Goldberg

Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis Geraint B. Rogers, Lucas R. Hoffman,

Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery Torsten Doenst, MD, PhD,

Volume 67, Issue 5, Pages (November 2017)

Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005 F.A. Millar, N.J. Simmonds, M.E. Hodson Journal.

Volume 38, Issue 1, Pages (January 2003)

F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal

Volume 63, Issue 1, Pages (July 2015)

Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection Isabelle Chemin,

H. White, A.M. Morton, S.P. Conway, D.G. Peckham

Reviewer Acknowledgment

Pathogenesis of cholestatic hepatitis C

Chimeric mouse model of hepatitis B virus infection

Experience using centralized spirometry in the phase 2 randomized, placebo-controlled, double-blind trial of denufosol in patients with mild to moderate.

David Adeboyeku, Sandra Scott, Margaret E. Hodson

Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience C.R.

Presentation transcript:

Fibrogenic impact of high serum glucose in chro nic hepatitis C Vlad Ratziu, Mona Munteanu, Fréderic Charlotte, Luminita Bonyhay, Thierry Poynard Journal of Hepatology Volume 39, Issue 6, Pages 1049-1055 (December 2003) DOI: 10.1016/S0168-8278(03)00456-2

Fig. 1 Fibrosis progression according to serum glucose. The time dependent variable was the duration of infection in years. The thick and thin lines represent patients with high (>6.1 mmol/l) or normal (<6.1 mmol/l) serum glucose, respectively. The percentage of patients free of significant fibrosis (F2, F3, F4) is plotted against the duration of infection. Journal of Hepatology 2003 39, 1049-1055DOI: (10.1016/S0168-8278(03)00456-2)